文献速递慢性静脉疾病血液透析通路

血液透析相关上腔静脉综合征患者低血压的危险因素

Risk factors for hypotension in patients with hemodialysis-associated superior vena cava syndrome.
PubMed 文献 · J Vasc Surg Venous Lymphat Disord · 2023-09-12

该回顾性队列纳入2019年1月至2021年12月四川大学华西医院肾脏内科194例维持性血液透析合并上腔静脉综合征患者,比较低血压组与非低血压组,多因素分析显示高血压史、隧道式带 cuff 导管、上腔静脉狭窄>70%或闭塞、左室后壁厚度、血清钙为独立危险因素,血管内干预后血压升高。

要点

  • 194例中85例发生低血压,低血压定义为非透析日血压<90/60 mm Hg。
  • 高血压史(OR 0.314)、左室后壁厚度(OR 0.772)、血清钙(OR 0.146)与低血压风险降低相关。
  • 隧道式带 cuff 导管(OR 3.997)、上腔静脉狭窄>70%或闭塞(OR 5.243)与低血压风险升高相关。

核心结论

  • 血液透析相关上腔静脉综合征患者低血压发生率较高。
  • 识别血液透析相关低血压的危险因素有助于潜在治疗策略的制定。
  • 血管内治疗有望改善血液透析患者上腔静脉综合征相关的低血压。

研究设计与样本

  • 回顾性队列研究,纳入2019年1月至2021年12月四川大学华西医院肾脏内科194例诊断为上腔静脉综合征的维持性血液透析患者,分为低血压组与非低血压组。
  • 低血压定义为非透析日血压<90/60 mm Hg。
  • 所有患者均接受血管内干预。

主要发现

  • 194例中85例发现低血压。
  • 低血压组与非低血压组在体重指数、高血压史、隧道式带 cuff 导管作为透析通路、奇静脉扩张、上腔静脉狭窄>70%或闭塞、腔静脉交界处闭塞、血清钙、左室后壁厚度、左室舒张末期容积、每搏输出量、左室射血分数方面差异显著。
  • 多因素 logistic 回归显示高血压史(OR 0.314;P = .027)、隧道式带 cuff 导管作为血管通路(OR 3.997;P < .001)、上腔静脉狭窄>70%或闭塞(OR 5.243;P < .001)、左室后壁厚度(OR 0.772;P = .044)、血清钙(OR 0.146;P = .005)为低血压的独立危险因素。
  • 血管内治疗后收缩压和舒张压均值较干预前显著升高(P < .001)。
  • 术后3、6、12个月上腔静脉一期通畅率分别为66.8%、58.7%、50.0%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: We analyzed the risk factors for hypotension in patients with hemodialysis-associated superior vena cava syndrome (SVCS) and effectiveness of endovascular intervention in hypotension related to SVCS. METHODS: This was a retrospective cohort study. A total of 194 maintenance hemodialysis patients diagnosed with SVCS who were admitted to the Department of Nephrology, West China Hospital of Sichuan University from January 2019 to December 2021 were selected and divided into a hypotension group and a nonhypotension group. Demographic and clinical data were compared. Hypotension simply refers to blood pressure levels of <90/60 mm Hg on a nondialysis day. All patients received endovascular intervention. RESULTS: Hypotension was found in 85 of the 194 patients. The following factors were significantly different between the hypotension and nonhypotension groups: body mass index, history of hypertension, tunneled-cuffed catheter as the means of dialysis access, azygos ectasis, SVC stenosis of >70% or occlusion, occlusion at the cavitary junction, serum calcium, diastolic left ventricular (LV) posterior wall thickness, LV end-diastolic volume, stroke output, and LV ejection fraction. Multivariate logistic regression analysis showed that hypertension history (OR, 0.314; P = .027), tunneled-cuffed catheter as vascular access (OR, 3.997; P < .001), SVC stenosis of >70% or occlusion (OR, 5.243; P < .001), LV posterior wall thickness (OR, 0.772; P = .044), and serum calcium (OR, 0.146; P = .005) were independent risk factors for hypotension. The mean values of systolic and diastolic blood pressure after intravascular treatment were significantly elevated from those before intervention (P < .001). The primary patency rates of SVC were 66.8%, 58.7%, and 50.0% at 3, 6, and 12 months after the procedure. CONCLUSIONS: The incidence of hypotension in patients with hemodialysis-associated SVCS is high. The identification of risk factors of hemodialysis-related hypotension provides insight into potential treatment strategies. Endovascular treatment is expected to improve hypotension related to SVCS in hemodialysis patients.

来源:J Vasc Surg Venous Lymphat Disord,查看原文。版权归原作者所有。

引用

  1. Zhao QY, Li Q, Cui TL, et al. Risk factors for hypotension in patients with hemodialysis-associated superior vena cava syndrome. J Vasc Surg Venous Lymphat Disord. 2023. PMID: 37708936. doi:10.1016/j.jvsv.2023.08.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。